Pantec Biosolutions to exhibit MEDICA 2010 World Forum in Düsseldorf, Germany on 17-20 November 2010

Ruggell, Liechtenstein, 17 November 2010- Pantec Biosolutions AG, a privately-owned company developing innovative transdermal drug delivery products, today announced its participation in the MEDICA International Trade Fair 2010, being held 17-20 November 2010 at the Düsseldorf Fairgrounds in Düsseldorf, Germany. Pantec Biosolutions will host a booth in the American Pavilion Hall 16, Booth Number A36. More than 135,000 visitors from over 100 different countries are expected to attend this year’s event.

At MEDICA, Pantec Biosolutions will make an announcement relating to their P.L.E.A.S.E. Professional^® system. P.L.E.A.S.E. Professional^® is a n affordable portable benchtop system with a diode pumped Er:YAG fractional ablative laser. Compared with the currently marketed lamp pumped systems, P.L.E.A.S.E. Professional^® is a small, lightweight and very cost efficient device with a variety of applications in conventional and aesthetic dermatology and in general medicine. P.L.E.A.S.E. Professional^® allows precise intraepidermal microporation in connection with improved transdermal drug delivery of new or existing drugs. This class 1 laser device requires little maintenance and clinicians using it have no need for safety protection.

“We are delighted to be exhibiting our P.L.E.A.S.E. Professional^® system for applications in drug delivery and aesthetic dermatology at such an important international event,” said Christof Stefan BoehlerSchubert, CEO Business Manager Dermatology of Pantec Biosolutions. “Our device has been clinically-tested and approved for easy-to-use, efficient, and painless application of biologicals in the treatment of certain dermatological conditions as well as for immunology and immunization applications.”

About Pantec Biosolutions and P.L.E.A.S.E.^®

Pantec Biosolutions AG is a private drug delivery company specialised in using laser microporation technology to deliver large molecular weight drugs into the epidermis for local or systemic uptake. Its proprietary P.L.E.A.S.E.^® (Painless Laser Epidermal System) platform enables efficient, needle-free and painless administration of biopharmaceutical drugs, in varying and individualised dosages, through partnered patch technology. The technology is currently in clinical trials for the delivery of IVF hormone therapy, a market with an estimated value of US$1.5 – 2 billion.

Pantec Biosolutions’ P.L.E.A.S.E.^® platform is available both for the development of the Company’s own pipeline and for penetration into new markets through strategic partnerships. Pantec Biosolutions is based in Ruggell, Liechtenstein.

For further details please contact:

At the Company Pantec Biosolutions AG
Dr. Christof Boehler, Chief Executive Officer
Tel: +423 377 1390
Email: info@pantec-biosolutions.com 

Media Relations College Hill Life Sciences
Douglas Pretsell, Account Director 
Tel: +49 (0)89 57 00 18 06 
Email: douglas.pretsell@collegehill.com